The infuluennce of remifenntanil to functions of endocrine system in perioperative patients(prospective study)

The infuluennce of remifenntanil to functions of endocrine system in perioperative patients(prospective study) - The infuluennce of remifenntanil to functions of endocrine system in perioperative patients(prospective study)

Status

Recruiting

Phases

Unknown

Study type

Interventional

Source

JPRN

Registry ID

JPRN-UMIN000013605

Enrollment

Registered

2014-04-02

Start date

2014-02-01

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Perioperative adult patients undergoing orthopedic surgery

Interventions

Using remifentanil Not using remifentanil

Eligibility

Sex/Gender

Male

Inclusion criteria

Inclusion criteria: Perioperative adult patients undergoing micro endoscopic discectomy or micro endoscopic laminoplasty

Exclusion criteria

Exclusion criteria: Patients with heart failure, severe valvular disease, not sinus rhythm and obesity(BMI>=30)

Design outcomes

Primary

Measure	Time frame
renin,aldosterone,cortisol	—

Countries

Japan

Contacts

Public ContactTakerou Terashi

Kagoshima Red Cross Hospital Department of anesthesiology

terashi@m2.kufm.kagoshima-u.ac.jp099-261-2111

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026